Fouremm,

This promisory note tell us minion retail shareholders a few things, one that a buyout is not that close, wouldn't need $350k if in a few months there a buyout, unless the $350k is need for the M & A lawyers( doubtful) It tell us also Zenith market cap is around $300 Million cap based on around $1.50 ish USD per share financing  with 150 million shares outstandng.  Zenith has postive  BP  collaboration partnership,  NIH paying for trials , recent  positive trial news and trials moving forward.  RVX on the otherhand is at $50 million market cap and seems stalled by financing  by the looks of it to move the trials forward. Unless a deal is negotiations.